EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 5.0% of their position (83.33K shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $10.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/4/2025ACC: 0001493152-25-009003
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+83.33K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
83.33K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+83.33K
Price / share
$0.12
Trade value
$10K
% of position
5.0%
3/4/2025
1.68M→1.76M
Total
Net shares
+83.33K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2025 | P · Purchase | +83.33K | $0.12 | $10K | 5.0% | 1.68M | 1.76M |
| Total | +83.33K | $10K | ||||||
Derivative Transactions0
No derivative transactions reported